Job Title: Assay Development Scientist / R&D Scientist – Cancer Diagnostics Location: OpenJob Type: Full-TimeDepartment: Research & DevelopmentReports To: Director of R&D / Head of Assay Development About OncoFirm Diagnostics…
Location: openJob Type: Full-TimeDepartment: Regulatory Affairs & Quality AssuranceReports To: VP of Regulatory Affairs / Head of Compliance About OncoFirm Diagnostics At OncoFirm Diagnostics, our mission is fueled by purpose—every…
Job Title: Molecular Biologist – Cancer Diagnostics Location: RemoteJob Type: Full-TimeDepartment: Research & DevelopmentReports To: Director of Scientific Affairs About OncoFirm Diagnostics At OncoFirm Diagnostics, our mission is deeply personal….
Job Title: Biochemist – Rapid Diagnostic Test Development Location: RemoteJob Type: Full-TimeDepartment: Research & DevelopmentReports To: Director of Assay Development About OncoFirm Diagnostics At OncoFirm Diagnostics, we are united by…
A distinguished member of a Scientific Advisory Council, which has made significant contributions to cancer immunotherapy, particularly in ovarian cancer. His research focuses on identifying tumor antigens and developing immunotherapeutic…
Carbohydrate antigen 72-4 (CA72-4) is a tumor-associated glycoprotein frequently studied as a biomarker for cancer, particularly gastric and gynecological malignancies. Here’s a detailed overview based on current research: Overview and…
AI-Driven Biomarkers: Transforming Cancer Detection Through Multimodal Intelligence Introduction The integration of artificial intelligence (AI) into healthcare has revolutionized biomedical research, diagnostics, and patient care. One of the most promising…
RNA Polymerase II Levels in Histone Genes: A Predictive Biomarker for Tumor Aggressiveness and Recurrence Introduction Histone genes play a fundamental role in DNA packaging and chromatin structure, and their…
FOR IMMEDIATE RELEASE Contact: Jonathan Adam Barash Email: [email protected] Phone: 516‑900‑2606 Website: www.oncofirmdiagnostics.com OncoFirm Diagnostics Corp. Announces Launch and Opens First Funding Round Up to $10 Million Advancing Early Cancer…
OncoFirm™ Electronic Reader cassette reader* (detailed information coming soon)… Cutting-Edge Digital Cancer Diagnostics Solutions Lateral Flow Electronic Reader (LFER) technology is an advanced diagnostic tool used to enhance and quantify…